Global MNI-caged-L-glutamate Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global MNI-caged-L-glutamate Market Insights, Forecast to 2034
MNI-caged-L-glutamate is a form of glutamate linked to a photo-protecting group, 4-methoxy-7-nitroindolinyl (MNI); it rapidly and efficiently releases L-glutamate (Cat. No. 0218) by photolysis (300 - 380 nm excitation) with a quantum yield in the 0.065-0.085 range.
Market Analysis and InsightsGlobal MNI-caged-L-glutamate Market
Global MNI-caged-L-glutamate market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, MNI-caged-L-glutamate industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
In terms of regions, North America is expected to remain the largest market during the forecast period.
Report Covers
This report presents an overview of global MNI-caged-L-glutamate market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global MNI-caged-L-glutamate market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, MNI-caged-L-glutamate introduction, etc. MNI-caged-L-glutamate Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of MNI-caged-L-glutamate
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal MNI-caged-L-glutamate Market
Global MNI-caged-L-glutamate market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, MNI-caged-L-glutamate industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
In terms of regions, North America is expected to remain the largest market during the forecast period.
Report Covers
This report presents an overview of global MNI-caged-L-glutamate market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global MNI-caged-L-glutamate market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
R&D Systems
Abcam
Stemgent
Cayman Chemical
Santa Cruz Biotechnology
STEMCELL Technologies
AbMole Bioscience
Bio-Techne
Segment by Type
Low Purity(Below 97%)
Purity(Above 97% and Below 99%)
High Purity(Above 99%)
Others
Segment by Application
Cancer Treatment
Neurological Treatment
Endocrinological Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, MNI-caged-L-glutamate introduction, etc. MNI-caged-L-glutamate Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of MNI-caged-L-glutamate
Chapter 13Methodology and Data Sources adopted by MRAResearch